CHIKUMI Jun 千酌潤

… Alternative Names

NANIWA Jun 浪花潤

Less

Researcher Number	70467702
Affiliation (Current)	2025: 鳥取大学, 保健管理センター, 助教
Affiliation (based on the past Project Information) *help	2024: 鳥取大学, 保健管理センター, 助教 2014 – 2015: 鳥取大学, 医学部附属病院, 医員 2010 – 2013: 鳥取大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Basic Section 58070:Lifelong developmental nursing-related
Keywords	Principal Investigator 卵巣癌 / 耐性遺伝子 / 感受性試験 / 抗癌剤感受性試験 / 薬剤耐性 / 上皮性卵巣癌 Except Principal Investigator QOL / 改善プログラム / 食習慣 / 最終糖化産物 … More / PMS / mTOR阻害剤 / PI3K阻害剤 / PIK3CA / 明細胞癌 / PI3K / 明細胞腺癌 / 卵巣癌 / FGFR2 / 卵巣明細胞腺癌 Less

PMS症状への終末糖化産物に着目した食習慣改善プログラムの開発と有効性の検証
- Principal Investigator
  
  藤田小矢香
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58070:Lifelong developmental nursing-related
- Research Institution
  Tottori University
Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary
- Principal Investigator
  
  Oishi Tetsuro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Genetic chemosensitivity test with novel drug-resistance genes in epithelial ovarian cancerPrincipal Investigator
- Principal Investigator
  
  NANIWA Jun
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University

All 2014 2013

All Journal Article

[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014
- Author(s)
  Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Oncology Report
  
  Volume: 32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014
- Author(s)
  Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada H.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 1 Pages: 61-69
- DOI
  10.1097/igc.0000000000000014
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014
- Author(s)
  Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 3 Pages: 444-453
- DOI
  10.1097/igc.0000000000000091
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013
- Author(s)
  Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., and Harada T.
- Journal Title
  
  Human Cell
  
  Volume: 26 Issue: 3 Pages: 121-127
- DOI
  10.1007/s13577-013-0062-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592517

1. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
2. SATO Syinya (10423261)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
3. SATO Seiya (30621007)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
4. HARADA Tasuku (40218649)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
5. SHIMADA Muneaki (40362892)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
6. OISHI Tetsuro (80359877)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
7. KIGAWA Junzo (00177784)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
8. 藤田小矢香 (20437528)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 服部多恵 (10920895)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 鈴木康江 (10346348)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 籠橋有紀子 (30369756)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 下廣寿 (90583758)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

CHIKUMI Jun 千酌 潤

NANIWA Jun 浪花 潤

Research Projects

Research Products

Co-Researchers

PMS症状への終末糖化産物に着目した食習慣改善プログラムの開発と有効性の検証

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Genetic chemosensitivity test with novel drug-resistance genes in epithelial ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014

Author(s)

Journal Title

Data Source

[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013

Author(s)

Journal Title

DOI

Data Source

CHIKUMI Jun 千酌潤

NANIWA Jun 浪花潤